Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder
This secondary analysis (n=82) of a Phase III RCT of MDMA-assisted therapy found significant improvements in both uncompassionate self-responding and compassionate self-responding across all six Self-Compassion Scale subscales, most with large effect sizes. Changes in self-compassion fully mediated the reductions in PTSD severity and depressive symptoms observed with MDMA-AT versus placebo plus therapy, though no significant effects were seen for alcohol or substance use outcomes.
Authors
- Richard Zeifman
- Gabrielle Agin-Liebes
Published
Abstract
Background
Posttraumatic stress disorder (PTSD) is a severe condition often complicated by co-occurring disorders, such as major depression, alcohol use disorder, and substance use disorders. A well-powered phase 3 randomized, placebo-controlled trial has shown that MDMA-assisted therapy (MDMA-AT) may be an effective treatment for severe PTSD. However, the psychological mechanisms driving the therapeutic effects of MDMA-AT remain unclear. One potential mechanism is self-compassion, which is commonly conceptualized as a balance between compassionate self-responding (CS) - encompassing self-kindness, common humanity, and mindfulness - and uncompassionate self-responding (UCS) - encompassing self-judgment, isolation, and over-identification.
Objective
This secondary analysis aimed to explore whether MDMA-AT enhances aspects of self-compassion and if changes in self-compassion mediate the therapy's effectiveness in reducing PTSD severity, depressive, and alcohol and substance use symptoms.
Method
Eighty-two adults diagnosed with severe PTSD participated in a double-blind trial comparing three sessions of either MDMA-AT or placebo combined with therapy. Measures of PTSD severity, depressive symptoms, alcohol and substance use, and self-compassion were collected at baseline and 18 weeks later.
Results
MDMA-AT led to statistically significant improvements in both UCS and CS. Significant improvements were also observed across all six subscales of the Self-Compassion Scale, including self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification, most with large effect sizes. Changes in UCS and CS significantly and fully mediated the effects of MDMA-AT compared to placebo plus therapy in reducing PTSD severity and depressive symptoms. Findings were not significant for alcohol and substance use outcomes.
Conclusions
These findings suggest that self-compassion may play a critical role in the therapeutic effects of MDMA-AT. Further research is needed to investigate the role of self-compassion in MDMA-AT to refine and develop more targeted, effective interventions for individuals with PTSD and co-occurring depression.
Research Summary of 'Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder'
Introduction
Posttraumatic stress disorder (PTSD) is a disabling condition with high personal and societal costs, and many patients do not respond adequately to currently available pharmacotherapies or trauma-focused psychotherapies. Agin-Liebes and colleagues note that Phase III data indicate MDMA-assisted therapy (MDMA-AT) produces large, clinically meaningful benefits for severe, chronic PTSD with acceptable tolerability and lower dropout than standard treatments, yet the psychological mechanisms that underpin these effects remain unclear. Self-compassion has been proposed as one such mechanism: low self-compassion is common in PTSD and is associated with depression, self-criticism, shame, avoidance and poorer treatment response, while interventions that increase self-compassion have reduced PTSD symptoms in other contexts. This secondary, exploratory analysis therefore aimed to test whether MDMA-AT specifically influences distinct dimensions of self-compassion and whether changes in self-compassion mediate the treatment's effects on PTSD severity. The investigators examined both compassionate self-responding (CS) and uncompassionate self-responding (UCS), along with the six subscales of the Self-Compassion Scale (self-kindness, self-judgment, common humanity, isolation, mindfulness, over-identification), and also explored relationships with depressive symptoms and hazardous alcohol and substance use.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Agin-Liebes, G., Zeifman, R. J., & Mitchell, J. M. (2025). Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder. European Journal of Psychotraumatology, 16(1). https://doi.org/10.1080/20008066.2025.2485513
References (9)
Papers cited by this study that are also in Blossom
Barone, W., Beck, J., Mitsunaga-Whitten, M. et al. · Journal of Psychoactive Drugs (2019)
Carhart-Harris, R. L., Murphy, K., Leech, R. et al. · Biological Psychiatry (2015)
Fauvel, B., Strika-Bruneau, L., Piolino, P. · Psychology of Consciousness Theory Research and Practice (2023)
Feduccia, A. A., Jerome, L., Yazar-Klosinski, B. et al. · Frontiers in Psychiatry (2019)
´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)
Mitchell, J., Bogenschutz, M. P., Lilienstein, A. et al. · Nature Medicine (2021)
Mitchell, J., Ot’alora G, M., van der Kolk, B. et al. · Nature Medicine (2023)
van der Kolk, B., Wang, J. B., Yehuda, R. et al. · PLOS ONE (2024)
Wardle, M. C., De Wit, H. · Psychopharmacology (2014)
Cited By (1)
Papers in Blossom that reference this study
Ramaekers, J. G., Kuypers, K. P. C., Vollenweider, F. X. · Molecular Psychiatry (2026)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.